NextBioMedical Co Ltd
KOSDAQ:389650
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/IC
Enterprise Value to Invested Capital (EV/IC) ratio compares a company`s total enterprise value to the capital invested in its business. It shows how efficiently the company`s market value reflects the funds used to generate returns.
Enterprise Value to Invested Capital (EV/IC) ratio compares a company`s total enterprise value to the capital invested in its business. It shows how efficiently the company`s market value reflects the funds used to generate returns.
Valuation Scenarios
If EV/IC returns to its 3-Year Average (17.3), the stock would be worth ₩68 498.67 (15% upside from current price).
| Scenario | EV/IC Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 15 | ₩59 400 |
0%
|
| 3-Year Average | 17.3 | ₩68 498.67 |
+15%
|
| 5-Year Average | 17.3 | ₩68 498.67 |
+15%
|
| Industry Average | 2.4 | ₩9 382.46 |
-84%
|
| Country Average | 0.8 | ₩3 262.51 |
-95%
|
Forward EV/IC
Today’s price vs future invested capital
Peer Comparison
| Market Cap | EV/IC | P/E | ||||
|---|---|---|---|---|---|---|
| KR |
N
|
NextBioMedical Co Ltd
KOSDAQ:389650
|
482.7B KRW | 15 | -4 098.6 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
161.2B USD | 11 | 56.5 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
158.6B USD | 2.2 | 25.1 | |
| US |
|
Stryker Corp
NYSE:SYK
|
120.5B USD | 3.2 | 37.4 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
101.9B USD | 1.5 | 22.3 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
84.8B USD | 2.3 | 23.7 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
47.2B USD | 4.7 | 43.3 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
38.3B EUR | 1.2 | 18.5 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
44.1B USD | 14.7 | 42.1 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
41.4B USD | 1.2 | 24 | |
| US |
|
Resmed Inc
NYSE:RMD
|
30.9B USD | 4.4 | 20.8 |
Market Distribution
| Min | 0 |
| 30th Percentile | 0.5 |
| Median | 0.8 |
| 70th Percentile | 1.7 |
| Max | 2 224.6 |
Other Multiples
NextBioMedical Co Ltd
Glance View
NextBioMedical Co Ltd is a KR-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Incheon, Incheon. The company went IPO on 2024-08-20. NextBioMedical Co Ltd is a Korea-based company mainly engaged in the manufacturing and sales of medical equipment. The firm is mainly engaged in the manufacturing and sales of medical equipment, such as endoscopic hemostatic agents and vascular embolic microspheres. In addition, the Company is also engaged in the research and development of medical equipment.
